These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 16039941

  • 1. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, Hsueh YM.
    Toxicol Appl Pharmacol; 2005 Aug 15; 206(3):299-308. PubMed ID: 16039941
    [Abstract] [Full Text] [Related]

  • 2. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
    Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ.
    Sci Total Environ; 2009 Apr 01; 407(8):2608-14. PubMed ID: 19187952
    [Abstract] [Full Text] [Related]

  • 3. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
    Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM.
    Toxicol Appl Pharmacol; 2007 Jan 15; 218(2):135-42. PubMed ID: 17173945
    [Abstract] [Full Text] [Related]

  • 4. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
    Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ.
    Cancer Causes Control; 2008 Oct 15; 19(8):829-39. PubMed ID: 18351295
    [Abstract] [Full Text] [Related]

  • 5. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
    Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, Chiu AW, Yang MH, Chen CJ, Hsueh YM.
    Toxicol Appl Pharmacol; 2007 Jan 15; 218(2):99-106. PubMed ID: 17196235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arsenic methylation and bladder cancer risk in Taiwan.
    Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Christiani DC.
    Cancer Causes Control; 2003 May 15; 14(4):303-10. PubMed ID: 12846360
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans?
    Yang CY.
    J Toxicol Environ Health A; 2006 Oct 15; 69(19):1797-804. PubMed ID: 16905509
    [Abstract] [Full Text] [Related]

  • 10. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.
    Wu MM, Chiou HY, Hsueh YM, Hong CT, Su CL, Chang SF, Huang WL, Wang HT, Wang YH, Hsieh YC, Chen CJ.
    Toxicol Appl Pharmacol; 2006 Oct 01; 216(1):168-75. PubMed ID: 16806340
    [Abstract] [Full Text] [Related]

  • 11. Blackfoot disease and arsenic: a never-ending story.
    Tseng CH.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005 Oct 01; 23(1):55-74. PubMed ID: 16291522
    [Abstract] [Full Text] [Related]

  • 12. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
    Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, Lue LC, Chen GS, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 1997 Aug 01; 6(8):589-96. PubMed ID: 9264271
    [Abstract] [Full Text] [Related]

  • 13. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
    Chen YC, Su HJ, Guo YL, Houseman EA, Christiani DC.
    Cancer Causes Control; 2005 Mar 01; 16(2):75-81. PubMed ID: 15868449
    [Abstract] [Full Text] [Related]

  • 14. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
    Huang SK, Chiu AW, Pu YS, Huang YK, Chung CJ, Tsai HJ, Yang MH, Chen CJ, Hsueh YM.
    Urol Int; 2008 Mar 01; 80(4):405-12. PubMed ID: 18587252
    [Abstract] [Full Text] [Related]

  • 15. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, Rettenmeier AW, Hirner AV, Obe G.
    Toxicol Appl Pharmacol; 2004 Dec 01; 201(2):156-65. PubMed ID: 15541755
    [Abstract] [Full Text] [Related]

  • 16. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan.
    Tseng CH, Chong CK, Chen CJ, Tai TY.
    Angiology; 1997 Apr 01; 48(4):321-35. PubMed ID: 9112880
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
    Shen J, Wanibuchi H, Waalkes MP, Salim EI, Kinoshita A, Yoshida K, Endo G, Fukushima S.
    Toxicol Appl Pharmacol; 2006 Feb 01; 210(3):171-80. PubMed ID: 15950995
    [Abstract] [Full Text] [Related]

  • 18. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system.
    Chang CC, Ho SC, Tsai SS, Yang CY.
    J Toxicol Environ Health A; 2004 Sep 10; 67(17):1353-61. PubMed ID: 15371236
    [Abstract] [Full Text] [Related]

  • 19. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY, Chiu HF, Chang CC, Ho SC, Wu TN.
    Environ Res; 2005 May 10; 98(1):127-32. PubMed ID: 15721893
    [Abstract] [Full Text] [Related]

  • 20. Assessing the human health risks from exposure of inorganic arsenic through oyster (Crassostrea gigas) consumption in Taiwan.
    Liu CW, Liang CP, Huang FM, Hsueh YM.
    Sci Total Environ; 2006 May 15; 361(1-3):57-66. PubMed ID: 16122780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.